Genomic Data Sets

In collaboration with Wellcome Sanger Institute, we have generated whole genome sequencing (WGS) and RNA sequencing (RNAseq) of the 21 primary mesothelioma cell lines available through Mesobank. Processed datasets providing information on the mutations as well as copy number alterations of well-established cancer driver genes can be provided. In addition, we are performing genome-wide Crispr/Cas9 screens and drug sensitivity testing on a sub-set of the Mesobank cell lines.

Researchers interested in accessing these datasets are asked to contact Mesobank who will facilitate a Data Access Agreement with the Wellcome Sanger Institute.